Molgramostim biosimilar (Reponex Pharmaceuticals)
莫拉司亭生物类似药 (Reponex Pharmaceuticals)
Report date: 2022/07/04 19:38:02
Base Information
Drug NameMolgramostim biosimilar (Reponex Pharmaceuticals)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesReponex Pharmaceuticals As
China Registration ClassN/A
Develop Information
Active CompaniesReponex Pharmaceuticals As
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A